Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1210Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | RegNo.IG0219003 | - |
| dc.date.accessioned | 2022-11-24T14:03:46Z | - |
| dc.date.available | 2022-11-24T14:03:46Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1210 | - |
| dc.description.abstract | Background: Oral Lichen Planus (OLP) is a common potentially malignant mucocutaneous disorder associated with chronic inflammation and cell-mediated immunological dysfunction. The current main stay of treatment is the administration of topical or systemic corticosteroids which are known to cause certain side-effects. Nigella sativa oil that is traditionally known to have anti-inflammatory, analgesic, wound healing, and antioxidant properties is gaining attention due to its minimal or no side effects. Aim: To evaluate and to compare the efficacy of Nigella sativa (75 % w/v) cream and Clobetasol propionate (0.05 % w/w) gel for the management of Oral Lichen Planus. Key words: EDTA, Push-out bond strength, AH Plus, Apexit Plus, MTA Fillapex | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.subject | Lichen Planus, Oral; Precancerous conditions; Pain; Clobetasol; Nigella sativa; Randomized Control Trial | en_US |
| dc.title | Comparative Evaluation of the Efficacy of Nigella Sativa(BlackSeed)(75%W/V)Cream and Clobetasol Propionate(0.05%W/W)Gel For the Management of Oral Lichen Planus-A Double Blinded Randomized Control Trial. | en_US |
| dc.type | Dissertations | en_US |
| Appears in Collections: | Oral Medicine and Radiology | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| MDS_Dr. LOKESH KUMAR_RegNo_IG0219003_2019-2022.pdf | 37.96 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.